These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9096196)

  • 41. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of amphotericin B in lipid emulsion for treating fungal septicemia in granulocytopenic patients.
    Macedo MC; Dulley FL; Ostronoff M; Machado CM; Zambon E; Matsumoto C; Dorlhiac-Llaccer P; Chamone DF
    Clin Infect Dis; 1994 Aug; 19(2):366-7. PubMed ID: 7986930
    [No Abstract]   [Full Text] [Related]  

  • 44. Administration of amphotericin B in lipid emulsion.
    Devlin J; Bailey E; Zarowitz B
    Crit Care Med; 1997 May; 25(5):892; author reply 893-4. PubMed ID: 9187613
    [No Abstract]   [Full Text] [Related]  

  • 45. Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis.
    Perfect JR; Wright KA
    J Antimicrob Chemother; 1994 Jan; 33(1):73-81. PubMed ID: 8157577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate---fat emulsion in HIV-infected patients with oral candidosis.
    Chavanet P; Clement C; Duong M; Buisson M; D'Athis P; Dumas M; Bonnin A; Portier H
    Clin Microbiol Infect; 1997 Aug; 3(4):455-461. PubMed ID: 11864156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B.
    Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL
    Antimicrob Agents Chemother; 1984 Mar; 25(3):366-7. PubMed ID: 6721469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comments concerning 'The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis'.
    Washington C; Davis SS
    Biopharm Drug Dispos; 1995 Aug; 16(6):529-31. PubMed ID: 7579034
    [No Abstract]   [Full Text] [Related]  

  • 51. Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers.
    Lamb KA; Washington C; Davis SS; Denyer SP
    J Pharm Pharmacol; 1991 Jul; 43(7):522-4. PubMed ID: 1682471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer.
    Blumberg EA; Reboli AC
    Clin Infect Dis; 1996 Mar; 22(3):462-6. PubMed ID: 8852963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs.
    Nieto J; Alvar J; Rodríguez C; San Andrés MI; San Andrés MD; González F
    Res Vet Sci; 2018 Apr; 117():125-132. PubMed ID: 29272720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.
    Lopez-Berestein G; Mehta R; Hopfer RL; Mills K; Kasi L; Mehta K; Fainstein V; Luna M; Hersh EM; Juliano R
    J Infect Dis; 1983 May; 147(5):939-45. PubMed ID: 6842027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis.
    Bouley M; Tod M; Chavanet P; Petitjean O
    Biopharm Drug Dispos; 1994 Aug; 15(6):485-92. PubMed ID: 7993986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphotericin B toxicity reduced by administration in fat emulsion.
    Anderson RP; Clark DA
    Ann Pharmacother; 1995 May; 29(5):496-500. PubMed ID: 7655134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial.
    Hasibi M; Jafari S; Manshadi SA; Asadollahi M; Salehi M; Zarch VV; Kouhi A
    Ear Nose Throat J; 2017 Feb; 96(2):E18-E22. PubMed ID: 28231371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pulmonary invasive aspergillosis: value of treatment with intravenous amphotericin B administered in a triglyceride emulsion for parenteral usage].
    Andrès E; Limacher JM; Bergerat JP
    Rev Med Interne; 1994 Apr; 15(4):244-9. PubMed ID: 8059144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
    Rouse MS; Tallan BM; Steckelberg JM; Henry NK; Wilson WR
    Antimicrob Agents Chemother; 1992 Jan; 36(1):56-8. PubMed ID: 1590700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.